Mühlbacher Axel C
Hochschule Neubrandenburg, IGM Institut Gesundheitsökonomie und Medizinmanagement, Brodaer Straße 2, 17033 Neubrandenburg, Germany.
Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):591-7. doi: 10.1586/14737167.2015.1038245. Epub 2015 Apr 20.
Patient centricity will initiate a change in healthcare decision-making paradigms. Patient-centered outcomes are a part of the solution to the challenges posed by complex decision problems due to multiple clinical and non-clinical outcomes. Multiple decision criteria require that clinical and regulatory decisions be based on the implicit value judgments of experts. Experts are under continuous pressure to ensure decisions are aligned with patient needs and result in positive performance. To fulfill this role and guarantee efficient decisions, experts must be fully informed about patient preferences; however, this assumption might not necessarily reflect reality. Health technology assessment focuses on the measurement of clinical effects, rather than the assessment of the impact of different outcomes on users' perceived value. Further evidence is needed to ensure that expert judgments are congruent with patient preferences. Therefore, patient preferences can be a valuable source of information to inform clinical and regulatory decision-makers.
以患者为中心将引发医疗保健决策范式的变革。以患者为中心的结果是解决因多种临床和非临床结果导致的复杂决策问题所带来挑战的一部分。多个决策标准要求临床和监管决策基于专家的隐含价值判断。专家们面临持续的压力，要确保决策符合患者需求并产生积极的效果。为了履行这一职责并保证决策高效，专家必须充分了解患者偏好；然而，这一假设不一定反映现实。卫生技术评估侧重于临床效果的测量，而非评估不同结果对用户感知价值的影响。需要更多证据来确保专家判断与患者偏好一致。因此，患者偏好可以成为为临床和监管决策者提供信息的宝贵信息来源。
